These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21098312)
1. Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans. Lee CR; Pretorius M; Schuck RN; Burch LH; Bartlett J; Williams SM; Zeldin DC; Brown NJ Hypertension; 2011 Jan; 57(1):116-22. PubMed ID: 21098312 [TBL] [Abstract][Full Text] [Related]
2. Vasodilation in black Americans: attenuated nitric oxide-mediated responses. Stein CM; Lang CC; Nelson R; Brown M; Wood AJ Clin Pharmacol Ther; 1997 Oct; 62(4):436-43. PubMed ID: 9357395 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans. Marczak ED; Marzec J; Zeldin DC; Kleeberger SR; Brown NJ; Pretorius M; Lee CR Pharmacogenet Genomics; 2012 Aug; 22(8):620-8. PubMed ID: 22668754 [TBL] [Abstract][Full Text] [Related]
4. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402 [TBL] [Abstract][Full Text] [Related]
5. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus. Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937 [TBL] [Abstract][Full Text] [Related]
6. Effects of black race on forearm resistance vessel function. Kahn DF; Duffy SJ; Tomasian D; Holbrook M; Rescorl L; Russell J; Gokce N; Loscalzo J; Vita JA Hypertension; 2002 Aug; 40(2):195-201. PubMed ID: 12154113 [TBL] [Abstract][Full Text] [Related]
7. Smoking impairs bradykinin-stimulated t-PA release. Pretorius M; Rosenbaum DA; Lefebvre J; Vaughan DE; Brown NJ Hypertension; 2002 Mar; 39(3):767-71. PubMed ID: 11897760 [TBL] [Abstract][Full Text] [Related]
8. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome. Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423 [TBL] [Abstract][Full Text] [Related]
9. The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Pretorius MM; Gainer JV; Van Guilder GP; Coelho EB; Luther JM; Fong P; Rosenbaum DD; Malave HA; Yu C; Ritchie MD; Vaughan DE; Brown NJ Clin Pharmacol Ther; 2008 Jan; 83(1):122-9. PubMed ID: 17522594 [TBL] [Abstract][Full Text] [Related]
10. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Lee CR; North KE; Bray MS; Fornage M; Seubert JM; Newman JW; Hammock BD; Couper DJ; Heiss G; Zeldin DC Hum Mol Genet; 2006 May; 15(10):1640-9. PubMed ID: 16595607 [TBL] [Abstract][Full Text] [Related]
11. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans. Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047 [TBL] [Abstract][Full Text] [Related]